|
Neonatal Intensive Care Drug Manual
|
| bet | 101/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Cefalexin
Revision Date : 16-12-2020
|
Approved : TC, KOH
|
Alert
|
High risk medicine. The Antimicrobial Stewardship Team recommends this drug is listed under the following category: Unrestricted.
|
Indication
|
Treatment of mild infections due to susceptible strains of bacteria.
Prophylaxis of urinary tract infections in patients at risk, such as vesicoureteric reflux.
|
Action
|
First generation cephalosporin. Bactericidal − inhibits cell wall synthesis in susceptible organisms. Most active against Gram-positive cocci, including MSSA and streptococci. Has have no activity against enterococci, MRSA or Listeria.1
|
Drug type
|
Cephalosporin antibiotic.
|
Trade name
|
APO-Cephalexin, Cefalexin Sandoz, Ialex, Ibilex, Keflex.
|
Presentation
|
125 mg/5 mL suspension
250 mg/5mL suspension
|
|
|
| |
